21st Century Oncology Holdings, Inc.
CIK 0001503518
Revenue (TTM)
—
Q3 Nov 2016
Net Income (TTM)
−$155.25M
+109.7% YoY
Q3 Nov 2016
EPS Diluted (TTM)
−$78,181.29
+48.0% YoY
Q3 Nov 2016
Gross Margin
—
Q3 Nov 2016
Operating Margin
—
Q3 Nov 2016
Net Margin
—
Q3 Nov 2016
Free Cash Flow (TTM)
—
Q3 Nov 2016
Cash
$49.7M
Q3 Nov 2016
Total Debt
$960.8M
Q3 Nov 2016
Shares Outstanding
1.06K sh
Q3 Nov 2016
Revenue & Net Income
EPS (Diluted)
Revenue Growth (YoY)
No data available for this metric.